Bausch & Lomb, a leading global eye health company, is headquartered in Great Britain and operates extensively across Europe, North America, and Asia. Founded in 1853, the company has established itself as a pioneer in the ophthalmic industry, focusing on the development of innovative products for vision correction and eye care.
Specialising in contact lenses, lens care products, and surgical devices, Bausch & Lomb is renowned for its commitment to quality and innovation. Their flagship products, including the popular Biofinity and PureVision contact lenses, are designed to enhance comfort and vision clarity, setting them apart in a competitive market.
With a strong market position, Bausch & Lomb has achieved numerous accolades for its contributions to eye health, making it a trusted name among eye care professionals and consumers alike.
+1 vs industry average
Bausch & Lomb’s score of 23 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Bausch & Lomb?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Health Services has typical carbon intensity
Industry performance
The Health Services industry has increased its overall emissions by 7% since 2019
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Bausch & Lomb's reported carbon emissions
In 2024, Bausch & Lomb reported total emissions of approximately 51.5 million kg CO2e from Scope 1 and 67.5 million kg CO2e from Scope 2, resulting in a combined total of approximately 119 million kg CO2e. This marks a slight increase from 2023, where emissions were approximately 50.1 million kg CO2e for Scope 1 and 64.3 million kg CO2e for Scope 2, totalling around 114.4 million kg CO2e. In 2022, the company recorded approximately 47.8 million kg CO2e in Scope 1 and 51.7 million kg CO2e in Scope 2, leading to a total of about 99.5 million kg CO2e.
Bausch & Lomb is committed to achieving Net Zero emissions by 2050, with this long-term target set to begin in 2023. This commitment encompasses all scopes of emissions, reflecting the company's dedication to addressing its carbon footprint comprehensively. The company has not yet established Science-Based Targets Initiative (SBTi) targets, but its ongoing efforts indicate a proactive approach to climate action.
As a global leader in the healthcare sector, Bausch & Lomb's emissions data and climate commitments are crucial for understanding its environmental impact and sustainability initiatives.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Bausch & Lomb’s Climate Goals (2030 & 2050)
1 goal2050
Bausch & Lomb U
Bausch & Lomb U.K. Limited is committed to achieving Net Zero emissions by 2050.
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 1 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Bausch & Lomb
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project